Chaoju Eye Care Holdings Limited (HKG:2219)
Hong Kong · Delayed Price · Currency is HKD 2.750
-0.010 (-0.36%)
Feb 13, 2026, 4:08 PM HKT
Chaoju Eye Care Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,369 | 1,405 | 1,370 | 990.04 | 997.79 | 794.28 | |
Revenue Growth (YoY) | -2.95% | 2.63% | 38.33% | -0.78% | 25.62% | 11.14% |
Cost of Revenue | 796.43 | 794.15 | 748.37 | 555.35 | 549.11 | 444.76 |
Gross Profit | 573 | 611.3 | 621.13 | 434.7 | 448.67 | 349.52 |
Selling, General & Admin | 343.57 | 362.06 | 327.45 | 223.32 | 201.93 | 166.42 |
Operating Expenses | 345.54 | 364.21 | 331.57 | 222.7 | 208.5 | 168.37 |
Operating Income | 227.46 | 247.09 | 289.56 | 212 | 240.17 | 181.15 |
Interest Expense | -11.14 | -10.65 | -12.22 | -11.9 | -10.54 | -12.75 |
Interest & Investment Income | 39.58 | 39.58 | 41.31 | 22.97 | 8.33 | 4.6 |
Currency Exchange Gain (Loss) | - | - | - | - | 2.2 | - |
Other Non Operating Income (Expenses) | 13.13 | 3.26 | -33.01 | -4.53 | -7.11 | -15.38 |
EBT Excluding Unusual Items | 269.03 | 279.28 | 285.64 | 218.54 | 233.04 | 157.62 |
Impairment of Goodwill | -38.76 | -20.39 | -13.83 | - | - | - |
Gain (Loss) on Sale of Investments | 10.28 | 3.83 | 28.3 | 20.19 | 0.04 | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.4 | - | - |
Asset Writedown | -4.38 | - | -0.87 | - | - | - |
Other Unusual Items | - | - | - | - | -22.5 | - |
Pretax Income | 236.17 | 262.72 | 299.24 | 239.14 | 210.58 | 157.62 |
Income Tax Expense | 72.84 | 76.51 | 78.51 | 55.94 | 52.94 | 37.09 |
Earnings From Continuing Operations | 163.33 | 186.21 | 220.74 | 183.2 | 157.64 | 120.53 |
Minority Interest in Earnings | 8.94 | 8.87 | 8.18 | 4.56 | 4.11 | 3.61 |
Net Income | 172.27 | 195.08 | 228.91 | 187.75 | 161.75 | 124.14 |
Net Income to Common | 172.27 | 195.08 | 228.91 | 187.75 | 161.75 | 124.14 |
Net Income Growth | -19.78% | -14.78% | 21.92% | 16.08% | 30.30% | 64.09% |
Shares Outstanding (Basic) | 691 | 689 | 696 | 706 | 625 | 550 |
Shares Outstanding (Diluted) | 693 | 691 | 697 | 706 | 625 | 550 |
Shares Change (YoY) | 0.45% | -0.77% | -1.37% | 13.12% | 13.55% | - |
EPS (Basic) | 0.25 | 0.28 | 0.33 | 0.27 | 0.26 | 0.23 |
EPS (Diluted) | 0.24 | 0.28 | 0.33 | 0.27 | 0.26 | 0.23 |
EPS Growth | -22.85% | -14.92% | 23.82% | 2.62% | 14.75% | - |
Free Cash Flow | 215.29 | 289.89 | 292.56 | 152.33 | 191.67 | 198.36 |
Free Cash Flow Per Share | 0.31 | 0.42 | 0.42 | 0.22 | 0.31 | 0.36 |
Dividend Per Share | 0.113 | 0.235 | 0.200 | 0.154 | 0.085 | - |
Dividend Growth | -64.83% | 17.21% | 30.37% | 80.93% | - | - |
Gross Margin | 41.84% | 43.49% | 45.36% | 43.91% | 44.97% | 44.01% |
Operating Margin | 16.61% | 17.58% | 21.14% | 21.41% | 24.07% | 22.81% |
Profit Margin | 12.58% | 13.88% | 16.71% | 18.96% | 16.21% | 15.63% |
Free Cash Flow Margin | 15.72% | 20.63% | 21.36% | 15.39% | 19.21% | 24.97% |
EBITDA | 314.41 | 332.97 | 361.99 | 267.87 | 286.8 | 225.18 |
EBITDA Margin | 22.96% | 23.69% | 26.43% | 27.06% | 28.74% | 28.35% |
D&A For EBITDA | 86.95 | 85.89 | 72.43 | 55.87 | 46.63 | 44.03 |
EBIT | 227.46 | 247.09 | 289.56 | 212 | 240.17 | 181.15 |
EBIT Margin | 16.61% | 17.58% | 21.14% | 21.41% | 24.07% | 22.81% |
Effective Tax Rate | 30.84% | 29.12% | 26.24% | 23.39% | 25.14% | 23.53% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.